Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants
A novel oral poliovirus vaccine type 2 (nOPV2) was well-tolerated among newborns and resulted in nearly all infants developing neutralizing antibodies after 2 doses, a recent trial reported.